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Abstract
Introduction Determinants of perioperative risk for RYGB are not well defined.
Methods Retrospective analysis of comorbidities was used to evaluate predictors of perioperative risk in 1,000 consecutive
patients having open RYGB by univariate analyses and logistic regression.
Results One hundred forty-six men, 854 women; average age 38.3±11.2 years; mean BMI 51.8±10.5 (range 24–116)
were evaluated. Average hospital stay (LOS) was 3.8 days; 87% <3 days. 91.3% of procedures were without major
complication. The most common complications were incisional hernia 3.5%, intestinal obstruction 1.9%, and leak 1.6%. 31
patients required reoperation within 30 days (3.1%). A 30-day mortality was 1.2%. Logistic regression evaluating predictors
of operative mortality correlated strongly with coronary artery disease (CAD) (p<0.01), sleep apnea (p=0.03), and age (p=
0.042). BMI>50 (0.6 vs 2.3%, p=0.03) and male sex were associated with increased mortality (1.3 vs. 4.0%, p=0.02). Sex-
specific logistic regression demonstrated males with angiographically proven CAD were more likely to die (p=0.028) than
matched cohorts. Age (p=0.033) and sleep apnea (p=0.040) were significant predictors of death for women.
Conclusion Perioperative mortality after RYGB appears to be affected by sex, BMI, age, CAD, and sleep apnea. Strategies
employing risk stratification should be developed for bariatric surgery.
Keywords Obesity.Morbidobesity.Roux-en-Ygastric
bypass.Morbidity.Mortality
Introduction
Obesity is currently the number one public health problem
in the United States, affecting one-third of all Americans
(http:/www.surgeongeneral.gov/topics/obesity). Approxi-
mately 5 to 8% have clinically severe or morbid obesity
and are candidates for bariatric surgery.
This obesity epidemic has been accompanied by a
geometric rise in the number of bariatric surgical proce-
dures. The American Society for Bariatric Surgery (ASBS)
estimates that the number of bariatric surgery procedures
has increased from approximately 20,000 in 1996 to over
140,000 in 2004 (http://www.asbs.org). During this period,
membership in the ASBS has also increased fivefold,
suggesting that many more surgeons are performing these
procedures. The most common bariatric procedure per-
formed in the United States is Roux-en-Y gastric bypass
(RYGB).
1
The explosive growth of bariatric surgery has garnered
much attention in the media, with much speculation about
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e-mail: lflancba@nshs.eduthe risks, both short- and long-term, of RYGB. Unfortu-
nately, to date, little information from large series is
available concerning the operative mortality of RYGB and
those factors that predict mortality. In 2002, Livingston
et al.
2 reported an operative mortality of 1.3% in 1,067
patients after open RYGB and found that only age over
55 years correlated with perioperative mortality. More
recently, Fernandez et al.
3 analyzed their patient cohort of
1,431 patients having open RYGB and found a 1.9%
mortality, which was associated with age, weight, longer
limb gastric bypass, and the occurrence of a leak or
pulmonary embolism.
This report is a multivariate analysis of preoperative
mortality and morbidity in 1,000 consecutive open RYGBs
performed over a 5-year period by a single surgeon (LF) in
at a single institution.
Materials and Methods
Bariatric Surgery Program The bariatric surgery program
at St. Luke’s–Roosevelt Hospital Center in New York City
was initiated in April 1999 and the first operation
performed in June 1999. The basis of this report consists
of 1,000 consecutive open RYGBs (primary cases and
revisions) performed by a single surgeon, LF, between June
1999 and June 2004.
Clinical Protocol and Surgical Technique All patients were
evaluated preoperatively and met generally accepted criteria
outlined by the NIH at its Consensus Development
Conference on Gastrointestinal Surgery for Severe Obesity.
4
In addition, all patients were routinely evaluated by a
registered dietitian experienced in the treatment of obesity.
Mental health and other specialty consultations were only
obtained if they were felt to be clinically indicated or were
required by an insurance carrier. All patients were evaluated
by an attending anesthesiologist before surgery.
Routine preoperative studies included: electrocardio-
gram, chest x-ray, gallbladder ultrasonography, serum
electrolytes, glucose, HbA1c, calcium, albumin, lipid
profile, liver function tests, complete blood count, platelets,
prothrombin time, partial thromboplastin time, INR, and
urinalysis. Over time, additional preoperative studies,
including serum insulin, iron, ferritin, vitamin B12, 25-OH
vitamin D, and thiamine (vitamin B1) were added.
RYGB was performed in a standard fashion with the
following common elements: (1) open technique; (2) 20–
30 ml pouch, nondivided stomach, TA 90B (US Surgical,
Norwalk, CT, USA) applied twice; (3) hand-sewn two-layer
retrocolic, antegastric gastrojejunostomy, 12 mm in length,
tested with methylene blue under pressure intraoperatively;
(4) side-to-side, functional end-to-end jejunojejunostomy
with dispSAble GIA (US Surgical) or LC (Ethicon Endo-
surgery, Sommerville, NJ, USA) 75 mm staplers, and TA55
(US Surgical) or TX 60 (Ethicon Endosurgery) staplers and
routinely oversewn with 3–0 silk Lembert sutures. The
biliopancreatic limb-length measured 75 cm along the
antimesenteric border for patients with BMI less than 50
and 150 cm for patients with BMI greater than or equal to 50.
The Roux or alimentary limb-length was 150 cm in all
patients. For the initial 14 cases, the stomach was divided
using the GIA-100 stapler. This technique was abandoned
and switched to the nondivided stomach after a stapler
malfunction led to a leak.
Closed suction drains were placed in all revisions,
patients with BMI>55, or if clinically indicated (e.g.,
identification of an intraoperative leak, technically difficult
anastomosis). Drains were removed as clinically indicated.
Fascia was closed with a running looped #1 PDS (Ethicon,
Sommerville) and infiltrated with 0.25% bupivacaine. The
subcutaneous space was drained with a #10 Jackson–Pratt
drain and the skin was closed with a running subcuticular
stitch.
The gallbladder was removed if gallstones were docu-
mented by preoperative ultrasound. Incisional or umbilical
hernias were primarily repaired if encountered, oftentimes
through a separate periumbilical incision.
Invasive monitoring was not used routinely and Foley
catheters were only placed if patients required invasive
hemodynamic monitoring or in the case of revisions or
when patients had multiple prior abdominal operations.
Nasogastric tubes were left in placed as clinically indicated
(intraoperative leak identified) or in patients with BMI>55.
All patients received perioperative antibiotics for 24 h,
cefazolin (2 g intravenously every 8 h for three total doses)
or clindamycin (900 mg intravenously every 6 h for four
doses). Prophylaxis against deep vein thrombosis consisted
of 5,000 units of unfractionated heparin administered
s u b c u t a n e o u s l ye v e r y8ha n dp n e u m a t i cc o m p r e s s i o n
stockings until ambulatory. All patients were given a PCA
pump (patient-controlled analgesia) for pain. Patients were
routinely cared for on a regular surgical floor, equipped for
severely obese patients. Patients with significant SA or
documented CAD were usually observed in the recovery
room overnight, and only rarely admitted to the intensive
care unit. On the morning of postoperative day 1, patients
were routinely studied with gastrograffin upper-GI studies.
If no leak was identified, they were given liquids for lunch
and advanced to soft food (yogurt, apple sauce, and cottage
cheese) for dinner and switched to oral pain medications.
Drains were usually removed before discharge. Patients
were discharged on POD #2 or #3 as indicated with the
following medications: a codeine-derivative for pain,
prenatal vitamins, iron polysaccharide, calcium citrate,
ursodeoxycholic acid, if the gallbladder was present.
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seen at 2 and 8 weeks, 6, 12, 18, 24 months, and yearly
thereafter. All routine follow-up appointments included
nutritional counseling and those after 2 weeks included
laboratory studies [serum electrolytes, glucose, HbA1c,
calcium, albumin, lipid profile, liver function tests, com-
plete blood count, platelets, serum insulin, iron, ferritin,
vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1)].
Follow-up was 74% at 1 year, 68% at 2 years, 59% at
3 years, 53% at 4 years, and 48% at 5 years.
Clinical Data and Data Analysis Clinical and laboratory
data were PC-based database prospectively maintained
since the program’s inception in 1999. Data collected
included: age, sex, height weight, BMI, race/ethnicity,
payer status, obesity-related comorbidities, operative pro-
cedure, duration of stay, mortality, major complications,
and death. Complications were classified as systemic
(prolonged intubation, deep venous thrombosis, pulmonary
embolism, and myocardial infarction/fatal arrhythmia) or
technical (incisional hernia, intestinal obstruction, leak/
perforation, dehiscence, GI bleeding, anastomotic stricture,
and anastomotic ulcer). Deaths were analyzed with respect
to BMI, demographics, comorbidities, and complications.
Superficial wound infections were not included; the
incidence of urinary tract infections was not tracked.
Nutritional complications were not evaluated because all
patients were routinely maintained on vitamins, iron, and
calcium supplements postoperatively; it would be impossi-
ble to determine the true incidence of any of these
nutritional deficiencies.
Univariate analyses and logistic regression with SPSS
11.0 were used to determine significance.
Results
The population consisted of 854 women and 146 men.
Their demographic characteristics are summarized in
Table 1. The prevalence of obesity-related comorbid
conditions is shown in Table 2.
The most common comorbidites encountered were
dyspnea on exertion (94%), joint pain/arthritis (92%), and
gastroesophageal reflux disease (59%). The comorbidites
typically associated with systemic disease included hyper-
tension (HTN, 39%), obstructive sleep apnea (SA, 24%),
dyslipidemia (46%), and asthma (15%). Approximately
23% of the patient population suffered from type II diabetes
mellitus (DM). At time of initial evaluation, 13.0% of this
diabetic patient subset had a prior history of insulin-
dependent DM, 57.6% had noninsulin dependent DM, and
23% had a previous diagnosis of DM intermittently
controlled on diet or were newly diagnosed with DM
during their preoperative evaluation. Six percent of the
patient population had angiographically documented histo-
ries of coronary artery disease (CAD) but were deemed
suitable risk by their respective specialists.
Procedures and Duration of Hospital Stay There were 966
primary RYGB and 34 revisions of failed bariatric
procedures (21—VBG, 5—RYGB, 8—other; all performed
at outside institutions) to RYGB. The median length of stay
for primary procedures was 2.4 days compared to 3.7 days
for revisions. Average (LOS) for all patients having
primary RYGB was 3.8 days with 87% of the group
leaving in 3 days or less.
Complications Overall, 91% of the procedures were with-
out systemic or technical complications.
The incidence of complications in relation to BMI is
summarized in Table 3. Overall, systemic complications
occurred rarely, but did not usually correlate with BMI. The
most common technical complications were incisional
hernia (3.5%), intestinal obstruction (1.9%), and leak/
perforation (1.6%).
Thirty-one patients (3.1%) required reoperation within
30 days of the original procedure. The indications for
reoperation within 30 days were leak/perforation (11),
intestinal obstruction (9), bleeding (4), rule-out leak (2),
dehiscence (4), and subphrenic abscess (1).
Indications for late operations (>30 days postoperative-
ly) included incisional hernia repair in 35 patients,
intestinal obstruction in 10 patients, and repair of leaks/
Table 1 Demographic Characteristics by Sex and Race
Women Men Total p-Value
Age (years) 38±1.0 (15–73) 40±11.9 (15–65) 38±11.17 (15–73) 0.064
Weight (kg) 134±27 (84–263) 170±43 (81–345) 139±33 (82–345) <0.01
BMI (kg/m
2) 51±10 (35–1,000) 55±13 (24–116) 51±10 (24–116) <0.01
Caucasian (28%) 238/853 (53%) 78/147 32% <0.01
African–American (30%) 253/853 (20%) 29/147 28% 0.01
Hispanic (42%)358/853 (27%)40/147 40% <0.01
Other (0.5%) 4/853 (0%) 0/147 0.4% 0.41
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ongoing postoperative complications. No patients required
reoperation for refractory anastomatic stricture or ulcer.
One patient developed a gastrogastric fistula after repair of
an early leak, which was treated expectantly since it was
clinically insignificant. No late gastrogastric fistulae were
identified.
Deaths Thirty-day mortality was 1.2%. Overall mortality
attributable to surgery was 1.5%. Patients with late deaths
due to unrelated events, such as motor vehicle accidents
(N=2) or drug overdoses (N=1), were excluded and not
classified as mortalities in the analysis. Mortality correlated
with BMI, with four (0.8%) patients having a BMI<50
dying compared to 11 (2.1%) patients with BMI≥50 (p=
0.03) (Table 3).
Causes of death after RYGB, along with their timing and
relationship to BMI are shown in Table 4. Two patients
died of fatal arrhythmias on POD #3 and #4. Both were
males, ages 48 and 54, with BMIs>50, DM, CAD, HTN,
and SA. Autopsies were performed in both instances and no
other precipitating factors were identified. One patient, a
43-year-old woman with a BMI 59, died of a pulmonary
embolism (identified at autopsy) at home after 2 weeks.
Six patients died from MSOF after postoperative leaks,
three from the gastrojejunostomy and three from perfo-
rations of the distal small bowel within the common
channel. Of these, four occurred and were diagnosed within
48 h of the initial RYGB and all were emergently explored.
All four developed MSOF and expired between 14 and
211 days postoperatively. Of the remaining two deaths, one
patient, 46-year-old woman with a BMI 79 and a history of
chronic ventilator dependence due to a paralyzed left
Table 3 Incidence of Complications after RYGB
Complication BMI<50 (%)
(N=481)
BMI>50 (%)
(N=515)
Total (%) p-Value
Systemic complications
Prolonged intubation 3 (0.6) 8 (1.5) 1.1 0.16 (NS)
Deep venous
thrombosis
0 (0) 2 (0.4) 0.2 NS
Pulmonary embolism 0 (0) 3 (0.6) 0.3 NS
MI/fatal arrhythmia 1 (0.2) 1 (0.2) 0.2 NS
Technical complications
Incisional hernia 10 (2.1) 25 (4.8) 3.5 0.019
Intestinal obstruction 10 (2.1) 9 (1.7) 1.9 NS
Leak 7 (1.5) 9 (1.9) 1.6 NS
Dehiscence 2 (0.4) 2 (0.4) 0.4 NS
GI bleeding requiring
transfusion
3 (0.6) 6 (1.2) 0.9 NS
Anastomotic ulcer 2 (0.4) 0 (0) 0.2 NS
Anastomotic Stricture 6 (1.2) 2 (0.4) 0.8 NS
Death 4 (0.8) 11 (2.1) 1.5 .03
Table 2 Prevalence of Obesity-Related Comorbid Conditions by Sex
Women (N=853) (%) Men (N=147) (%) Total (%) p-Value
Type II diabetes mellitus 177 (21) 54 (37) 23 <0.01
Hypertension 310 (36) 79 (54) 39 <0.01
CAD/CHF 29 (3) 26 (18) 6 <0.01
Dyslipidemia 376 (44) 80 (54) 47 0.02
Sleep apnea 172 (20) 63 (43) 24 <0.01
Asthma 135 (16) 16 (11) 15 0.12
Dyspnea on exertion 811 (95) 127 (86) 48 <0.01
GERD 513 (60) 77 (52) 59 0.08
Osteoarthritis 791 (93) 126 (87) 92 <0.01
Urinary stress incontinence 430/(50) 5 (3) 44 <0.01
Irregular menses 276 (32) NA 32 NA
CAD/CHF coronary artery disease/congestive heart failure, GERD gastroesophageal reflux disease
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leak and multiple intestinal fistulae and eventually suc-
cumbed to MSOF. The other patient, a 43-year-old woman,
BMI 43, had undergone a laparoscopic RYGB at another
institution that was complicated by a strangulated internal
hernia, massive intestinal gangrene, and short-bowel syn-
drome. She underwent a reversal of her RYGB with
reconstruction of her GI tract, but developed multiple small
bowel fistulae 2 weeks postoperatively and died of MSOF
several months later.
Three patients died from a severe systemic inflammatory
response syndrome (SIRS) with MSOF accompanied by
extremely high fevers, without any identifiable source. One
was a 70-year-old woman with BMI 68 underwent
reexploration for an early postoperative small bowel
obstruction. The others were a 54-year-old woman with a
BMI 47, DM, HTN, and SA and a 37-year-old male with
BMI 94 and severe SA and HTN. Each developed SIRS
and MSOF with temperatures of 105–107°F and hyper-
dynamic circulations. No intraabdominal or other sources
were identified despite numerous cultures and radiologic
studies.
Three patients died of bleeding complications. A 43-
year-old woman with a BMI 48 suffered progressive
hypotension and tachycardia in the recovery room postop-
eratively. These symptoms were initially addressed with
rehydration allowing the patient’s hematocrit to fall to a
level where hypovolemic shock and resulting coagulopathy
obscured efforts to surgically control or identify a single
source. A 31-year-old woman with a BMI 50 was returned
to the OR 4 h postoperatively for control of bleeding from
the small bowel mesentery. After this second procedure, she
developed SIRS, temperatures of 106°F, and MSOF, with
no identifiable source of sepsis. A 54-year-old male with a
BMI 56 and a history of HTN, CAD, and chronic atrial
fibrillation suffered a postoperative myocardial infarction
and developed a coagulopathy complicated by a massive
intraspenic hematoma after restarting coumadin, which
rapidly progressed to anuria and MSOF. Attempts to
reverse his anticoagulation and control the bleeding angio-
graphically were unsuccessful.
The necessity for reoperation within 30 days of the
original procedure was particularly ominous. Overall, the
incidence of death after a second operative procedure
within 30 days was 9/31 (29%). Two of the 16 patients
with a BMI<50 who required reoperation within 30 days
died (12.5%) compared to 7 out of 15 patients with BMI≥
50 (47% p=0.03). This is similar to the mortality for the
entire series where 0.8% for patients with a BMI<50 died
compared to 2.1% for patients with BMI≥50 (p=0.03).
However, among those 15 patients classified as operative
deaths for the entire series, 9 (60%) died after their second
operative procedure.
Logistic regression demonstrated that CAD [LR 7.5 p<
0.01 (95% CI 2.2 to 25.3)], and SA [LR 3.3 p=0.03 (95%
CI 1.1 to 10.1)], followed by age [LR 1.06 p=0.042 (95%
CI 1.00 to 1.12)], were risk factors for death in all patients
(Table 5). Although a small sample set, 12.7% of patients
with CAD died (7/55) and 29% of patients with BMI>50
and CAD and SA died.
Although the average BMI of males was slightly greater
than that of females (55.2 vs 51.2 kg/m
2, p<0.01), the two
populations also differed in characteristics other than BMI.
The male population had a significantly significant greater
prevalence of DM, HTN, CAD, dyslipidemia, and SA.
Females had a greater prevalence of pulmonary comorbid-
ities, including asthma and dyspnea on exertion (Table 2).
When logistic regression was performed specific to the
subsets of sex, males with angiographically demonstrated
CAD were 30 times more likely to die [LR 30.1 p=0.028
(95% CI 1.4 to 631.4)]. Logistic regression did not identify
CAD as a significant predictor when the analysis was
limited to women. Predictors of death for women include
Table 5 Logistic Regression Evaluation of Patient Comorbidity as
Predictors of Mortality
p-Value Relative
Risk
95% Confidence
Interval
Age 0.042 1.059 1.002–1.120
BMI 0.130 1.025 0.993–1.058
Female 0.612 0.729 0.215–2.474
DM 0.852 0.889 0.259–3.054
HTN 0.257 2.085 0.585–7.438
CAD 0.001 7.446 2.195–25.258
Dyslipidemia 0.099 0.359 0.106–1.211
Asthma 0.070 3.065 0.913–10.293
SA 0.033 3.342 1.104–10.115
SOB 0.693 0.644 0.073–5.725
Table 4 Causes of Early and Late Deaths Related to BMI
Cause of death Early (<30 days)
(N=11)
Late (>30 days)
(N=4)
BMI<
50
BMI≥
50
BMI<
50
BMI≥
50
MI/arrhythmia 0 2 0 0
Pulmonary/PE 0 1 0 0
MSOF 2
0 leak 1 2 1 2
MSOF 2
0 bowel
obstruction
0100
MSOF cause unknown 1 1 0 0
Bleeding complications 1 2 0 0
PE Pulmonary embolism, MSOF multisystem organ failure
504 J Gastrointest Surg (2007) 11:500–507age [LR 1.07 p=0.033 (95 % CI 1.0 to 1.14) and SA [LR
4.1 p=0.040 (95% CI 1.07 to 16.2)].
Logistic regression was repeated specific to race. When
limited to Caucasian patients only, Caucasians with CAD
were 58 times more likely to die [LR 58.8 p<0.01 (95% CI
4.8 to 716.9)] than those Caucasians without CAD.
Increasing BMI was also significant among Caucasians.
[LR 1.08 p=0.02 (95% CI 1.01 to 1.16)]. Evaluation of
African–American patients demonstrated that only SA was
significant [LR 19.1 p=0.03 (95% CI 1.29 to 282.8)].
Regression of the Hispanic population did not identify a
specific factor. One-way ANOVA did not demonstrate any
significant differences in prevalence of death or CAD
between the three racial groups for the entire population or
specific to sex.
Hispanic patients had significantly less SA than either
the Caucasian or African–American patients (18.1 vs 25.6
and 27.4%, respectively (p=0.01)). When examined spe-
cifically in relation to sex, there were no differences among
prevalence of SA in the males. African–American women,
however, had the greatest prevalence of SA (26.4%)
compared to Caucasian (18.9%) and Hispanic (15.7%)
women (p<0.01).
Discussion
The tremendous growth of bariatric surgery over the past
several years has spawned much interest in its complica-
tions and mortality, first in the media, but most recently in
the public health arena as well. Health and malpractice
insurance carriers as well as governmental agencies and
professional societies are evaluating the risks of bariatric
surgery and the surgeons that perform it. In several states,
insurance companies have stopped covering bariatric
surgery at the same time that the Centers for Medicare
and Medicaid Services have approved coverage for them.
Several malpractice carriers have stopped issuing policies
for surgeons performing bariatric procedures while others
are categorizing bariatric surgery as a high-risk subspecialty
area, similar to obstetrics and neurosurgery, and increasing
premiums accordingly. In each of these instances, the
overriding fear or consideration appears to be that the risks
associated with bariatric surgery are excessively high.
Much of the information being utilized in this regard has
come form series utilizing pooled data from multiple
smaller series or government databases.
1,5–9 Buchwald et
al.
5 performed a metaanalysis of 16,944 patients which
included 7,074 patients that underwent gastric bypass (open
and laparoscopic) in 44 studies with a 30-day mortality rate
of 0.5%. Several authors have reported that complication
rates of bariatric surgery were inversely correlated with case
loads, reporting mortality rates of in the range of 0.1–0.5%
for surgeons more than 100 or 150 cases per year.
6–8 Flum
et al.
9 recently reported 30- and 90-day mortality rates of
2.0 and 2.8%, respectively in Medicare beneficiaries having
bariatric surgery, with men having higher rates than women
and those over 65 years of age having higher rates than
those younger than 65. Many of these series lack data
concerning BMI and comorbidities, making risk assessment
difficult or impossible. In one large series from a single-
center, Christou et al.
10 reported a 30-day mortality of 0.4%
in 1,035 patients undergoing RYGB, of whom 820 had
open RYGB. No details about preexisting comorbidities or
perioperative complications were given.
The results of these pooled series differ from those in
several large series of open gastric bypasses
2,3,11. Living-
ston et al.
2 reported an operative mortality of 1.3% in 1,067
patients after open RYGB. In his series, mean BMI was
53.6 kg/m
2, mean age 42.3 years, and the incidence of
comorbidities was diabetes (23%), hypertension (48%), and
sleep apnea (39%). Only male sex was predictive of severe
life-threatening complications; mortality in patients over
55 years was significantly greater than in patients under 55
(3.5 vs 1.1%, p<0.05). More recently, Fernandez et al.
3
analyzed their patient cohort of 1,431 patients having open
RYGB and found a 1.9% mortality, which was associated
with age, weight, longer limb gastric bypass, and the
occurrence of a leak or pulmonary embolism. In that series,
the mean BMI was 53.3, mean age 40.7 years, and
incidence of serious comorbidities was diabetes (19.5%),
hypertension (51%), and sleep apnea (33%). In both of
these series, the BMI was higher, the patients were older
and the incidence of serious comorbidities, such as
diabetes, hypertension, dyslipidemia, and sleep apnea,
higher. Pories et al.
11 reported a 1.5% perioperative
mortality rate, with 0.8% dying of sepsis, 0.5% dying of
pulmonary embolism, and 0.2% of an unknown cause.
Additional information regarding the incidence of leaks,
bowel obstructions and other complications was not
reported as these were not the focus of the original paper.
Similarly, in the present series, the 30-day mortality rate
was 1.2% in 1,000 patients with a mean BMI of 52 kg/m
2.
The prevalence of preoperative comorbidities was compara-
ble to the larger series (diabetes—23%, hypertension—39%,
dyslipidemia—46%, coronary artery disease/congestive
heart failure—5.5%, sleep apnea—23.5%, and asthma—
15%) and generally higher than in the pooled series. The
incidence of leaks and postoperative small bowel obstruction
in our series was comparable to the other series. The
incidence of pulmonary embolism was less than those
reported, perhaps related to the use of both pneumatic
compression stockings and subcutaneous heparin and early
ambulation with a shorter length of stay. Although the
incidence of incisional hernia in our series was low (3.5%),
this may well be affected by our suboptimal follow-up.
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series (73%). In six patients, this resulted from leaks or
perforations; in one it followed a bowel obstruction, in two
it followed postoperative hemorrhage and in two patients,
the cause was never determined. In each of these instances,
the complication was identified early and appropriate
treatment and supportive care instituted. In four of the
patients, the clinical course of SIRS and MSOF was
characterized by extremely high temperatures (>105°F),
with no apparent source ever identified. To our knowledge,
this “syndrome” has not been reported, but may be due to
the fact that the enormous adipose tissue stores in these
patients may act as a “metabolic sink”, releasing cytokines
and other mediators and perpetuating this extreme systemic
inflammatory response. Two of the deaths were due to fatal
arrhythmias, both in patients with known CAD, who were
extensively evaluated preoperatively. The death due to
pulmonary embolism occurred after discharge, even though
the patient received prophylaxis with both heparin and
pneumatic compression stockings in the hospital. The
remaining death due to exsanguination was clearly
preventable.
Although males were significantly heavier and had
higher BMIs than women, sex was not an independent
predictor of morbidity. However, the presence of angio-
graphically documented coronary artery disease was par-
ticularly ominous in men. Males with angiographically
demonstrated CAD were 30 times more likely to die. In
women, predictors of death included age and SA, but not
CAD. With respect to race, Caucasian males with BMI>50
and CAD were most likely to die, whereas SA was a
predictor in African–American men. There were no
predictors in Hispanics. Despite the increased mortality in
Caucasian males with CAD, these patients were not
candidates for cardiac revascularization and extreme weight
loss was the only intervention thought to make a beneficial
health impact.
Based upon our data and those of others
2,3,11, it appears
that the risk of open RYGB is in the range of 1–2%. Risk
appears to be adversely affected by increasing BMI and
those factors with which it is often associated namely male
sex and coronary artery disease. How this compares with
the perioperative mortality after laparoscopic RYGB is still
unclear because many series of patients having laparoscopic
RYGB do not include patients with the highest BMIs,
above 60 or 70 kg/m
2, or patients having revisional surgery.
A perioperative mortality rate of 1.2% after RYGB
compares favorably with that after other common surgical
procedures. For example, perioperative mortality after
elective surgery for abdominal aortic aneurysms has been
reported at 3.1–4.7% overall, 1.0–2.7% in patients under
65 years of age, and 3.5–5.2% in patients over 65 years of
age.
12 Using Medicare data adjusted for high volume
surgeons, Birkmeyer et al.
13 reported perioperative mortal-
ity rates of 4.5% for colectomy, 8.6% for gastrectomy, 8.4%
for esophagectomy, 3.8% for pancreatic resection, 4.0% for
pulmonary lobectomy, and 10.7% for pneumonectomy.
While it is true that all of these patients were over 65 years
of age, the fact still remains that these perioperative
mortality rates are all substantially greater than that after
RYGB (even in Medicare recipients, as recently reported
9)
and neither the public, the press, the insurance industry, or
various state Departments of Health are appalled or
alarmed, or calling for a moratorium on those procedures.
This is not meant to suggest that every effort should not be
made to lessen the risks of bariatric surgery and to improve
operative mortality, but rather to inject some proportionality
into the discussion. The importance of such careful analysis
of bariatric surgical data, including its limitations, and the
need to continue to offer bariatric surgery to those patients
for whom it constitutes the best available treatment has
recently been emphasized.
14 In his 2004 PERSPECTIVE,
Surgery for Severe Obesity, Steinbrook
15 quotes Robert
Brolin, MD, cautioning physicians and the public “...to
reconcile the fact that the operation has a real mortality and
it will continue to have a real mortality under the best of
circumstances. Some of these patients are just profound
operative risks for any kind of surgical intervention...The
sickest ones are the ones who benefit the most, but they are
also the highest risk”.
Conclusion
RYGB can be performed with acceptable perioperative
morbidity in patients over a wide range of BMIs. Patients
with BMI≥50 have a higher morality for both initial
operations and after reexploration. Age, coronary artery
disease, and obstructive sleep apnea correlate with peri-
operative mortality. These three comorbidities were more
prevalent in these patients and may contribute to this
finding.
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